Good morning :)
Place Order
Add to Watchlist

Vivo Bio Tech Ltd

VIVOBIOT Share Price

36.001.07% (+0.38)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Biotechnology
Smallcap

With a market cap of ₹72 cr, stock is ranked 3,329

High Risk

Stock is 3.66x as volatile as Nifty

VIVOBIOT Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Biotechnology
Smallcap

With a market cap of ₹72 cr, stock is ranked 3,329

High Risk

Stock is 3.66x as volatile as Nifty

VIVOBIOT Performance & Key Metrics

VIVOBIOT Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
9.891.32—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.726.420.79%

VIVOBIOT Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

VIVOBIOT Company Profile

Vivo Bio Tech Limited is a biotechnology company that operates as a contract research organization (CRO) offering drug development and discovery services. It offers services in the areas of In vitro, In vivo, toxicity studies etc.

VIVOBIOT Similar Stocks (Peers)

Compare with peers Compare with peers 

VIVOBIOT Similar Stocks (Peers)

Compare with peers Compare with peers 
Biocon Ltd
BIOCON
PE Ratio
49.28
49.28
1Y Return
5.54%
5.54%
Buy Reco %
73.33
73.33
Onesource Specialty Pharma Ltd
ONESOURCE
PE Ratio
-1,261.55
-1,261.55
1Y Return
15.75%
15.75%
Buy Reco %
100.00
100.00
Sai Life Sciences Ltd
SAILIFE
PE Ratio
95.87
95.87
1Y Return
2.29%
2.29%
Buy Reco %
66.67
66.67
Acutaas Chemicals Ltd
ACUTAAS
PE Ratio
59.14
59.14
1Y Return
69.15%
69.15%
Buy Reco %
100.00
100.00
Panacea Biotec Ltd
PANACEABIO
PE Ratio
-304.53
-304.53
1Y Return
196.30%
196.30%
Buy Reco %
0.00
0.00
Compare with Peers

VIVOBIOT Forecast

VIVOBIOT Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

VIVOBIOT

VIVOBIOT

Income

Balance Sheet

Cash Flow

VIVOBIOT Income Statement

VIVOBIOT Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -1.46%, vs industry avg of 21.2%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.66% to 0.23%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 10.43%, vs industry avg of 20.34%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue34.5347.1355.8455.4051.8651.4952.2745.4951.4851.48
Raw Materialssubtract8.6212.6012.4110.909.917.974.934.6526.1626.16
Power & Fuel Costsubtract2.912.872.934.695.783.564.273.93
Employee Costsubtract5.507.669.5810.008.579.4213.5210.68
Selling & Administrative Expensessubtract8.1412.3312.308.7511.789.994.795.03
Operating & Other expensessubtract1.330.669.108.54-2.074.362.88-0.10
Depreciation/Amortizationsubtract3.904.645.065.175.597.459.279.299.029.02
Interest & Other Itemssubtract1.292.372.643.103.674.277.997.957.507.50
Taxes & Other Itemssubtract0.330.88-0.42-0.192.942.271.971.541.511.51
EPS2.683.252.023.524.331.591.821.694.764.89
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00
See Costs

VIVOBIOT Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

VIVOBIOT Stock Peers

VIVOBIOT Past Performance & Peer Comparison

VIVOBIOT Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareBiotechnology

Valuation

Technical

Forecast

ScreenerCompare valuation-basic on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Vivo Bio Tech Ltd9.891.32—
Biocon Ltd49.281.980.30%
Onesource Specialty Pharma Ltd-1,261.5557.26—
Sai Life Sciences Ltd95.8716.73—

VIVOBIOT Stock Price Comparison

Compare VIVOBIOT with any stock or ETF
Compare VIVOBIOT with any stock or ETF
VIVOBIOT
Loading...

VIVOBIOT Holdings

VIVOBIOT Shareholdings

VIVOBIOT Promoter Holdings Trend

VIVOBIOT Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

VIVOBIOT Institutional Holdings Trend

VIVOBIOT Institutional Holdings Trend

Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 1.31%

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

VIVOBIOT Shareholding Pattern

VIVOBIOT Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding39.06%0.00%0.00%0.00%60.94%

Mar 2025

Apr 2025

May 2025

Jun 2025

VIVOBIOT Shareholding History

VIVOBIOT Shareholding History

SepDec '24MarAprMayJun0.00%0.00%0.00%0.00%0.00%0.00%

VIVOBIOT Insider Trades & Bulk Stock Deals

VIVOBIOT Insider Trades & Bulk Stock Deals

Loading...

smallcases containing VIVOBIOT stock

smallcases containing VIVOBIOT stock

Looks like this stock is not in any smallcase yet.

VIVOBIOT Events

VIVOBIOT Events

VIVOBIOT Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

VIVOBIOT has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

VIVOBIOT Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

VIVOBIOT has not given any dividends in last 5 years

VIVOBIOT Dividends

VIVOBIOT Dividends

Hmm, looks like data is unavailable here. Please come back after some time

VIVOBIOT Stock News & Opinions

VIVOBIOT Stock News & Opinions

Earnings
Vivo Bio Tech consolidated net profit rises 43.24% in the March 2025 quarter

Net profit of Vivo Bio Tech rose 43.24% to Rs 1.06 crore in the quarter ended March 2025 as against Rs 0.74 crore during the previous quarter ended March 2024. Sales rose 4.51% to Rs 12.29 crore in the quarter ended March 2025 as against Rs 11.76 crore during the previous quarter ended March 2024. For the full year,net profit rose 187.75% to Rs 7.28 crore in the year ended March 2025 as against Rs 2.53 crore during the previous year ended March 2024. Sales rose 2.68% to Rs 46.67 crore in the year ended March 2025 as against Rs 45.45 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales12.2911.76 5 46.6745.45 3 OPM %40.8545.66 -43.9546.40 - PBDT3.493.86 -10 17.8113.35 33 PBT1.241.43 -13 8.794.06 117 NP1.060.74 43 7.282.53 188 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Vivo Bio Tech schedules board meeting

Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 19 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Vivo Bio Tech EGM scheduled

Vivo Bio Tech announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 7 February 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
Vivo Bio Tech consolidated net profit declines 37.88% in the December 2024 quarter

Net profit of Vivo Bio Tech declined 37.88% to Rs 0.82 crore in the quarter ended December 2024 as against Rs 1.32 crore during the previous quarter ended December 2023. Sales declined 4.98% to Rs 12.21 crore in the quarter ended December 2024 as against Rs 12.85 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales12.2112.85 -5 OPM %45.3749.65 - PBDT3.714.18 -11 PBT1.461.91 -24 NP0.821.32 -38 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Vivo Bio Tech schedules board meeting

Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 9 January 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Vivo Bio Tech to convene board meeting

Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 21 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Vivo Bio Tech consolidated net profit rises 1484.85% in the September 2024 quarter

Net profit of Vivo Bio Tech rose 1484.85% to Rs 5.23 crore in the quarter ended September 2024 as against Rs 0.33 crore during the previous quarter ended September 2023. Sales rose 30.02% to Rs 12.04 crore in the quarter ended September 2024 as against Rs 9.26 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.049.26 30 OPM %46.4352.48 - PBDT8.162.77 195 PBT5.870.46 1176 NP5.230.33 1485 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Vivo Bio Tech to hold board meeting

Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Vivo Bio Tech to convene AGM

Vivo Bio Tech announced that the 37th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live
Earnings
Vivo Bio Tech consolidated net profit rises 21.43% in the June 2024 quarter

Net profit of Vivo Bio Tech rose 21.43% to Rs 0.17 crore in the quarter ended June 2024 as against Rs 0.14 crore during the previous quarter ended June 2023. Sales declined 12.52% to Rs 10.13 crore in the quarter ended June 2024 as against Rs 11.58 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales10.1311.58 -13 OPM %43.1438.77 - PBDT2.452.54 -4 PBT0.220.25 -12 NP0.170.14 21 Powered by Capital Market - Live

11 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Vivo Bio Tech Ltd (VIVOBIOT) today?

    The share price of VIVOBIOT as on 11th July 2025 is ₹36. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Vivo Bio Tech Ltd (VIVOBIOT) share?

    The past returns of Vivo Bio Tech Ltd (VIVOBIOT) share are
    • Past 1 week: -3.10%
    • Past 1 month: -8.64%
    • Past 3 months: 3.80%
    • Past 6 months: -21.00%
    • Past 1 year: -2.52%
    • Past 3 years: 17.39%
    • Past 5 years: 27.80%

  3. What are the peers or stocks similar to Vivo Bio Tech Ltd (VIVOBIOT)?

    The peers or stocks similar to Vivo Bio Tech Ltd (VIVOBIOT) include:

  4. What is the market cap of Vivo Bio Tech Ltd (VIVOBIOT) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vivo Bio Tech Ltd (VIVOBIOT) is ₹72.08 Cr as of 11th July 2025.

  5. What is the 52 week high and low of Vivo Bio Tech Ltd (VIVOBIOT) share?

    The 52-week high of Vivo Bio Tech Ltd (VIVOBIOT) is ₹56.90 and the 52-week low is ₹31.20.

  6. What is the PE and PB ratio of Vivo Bio Tech Ltd (VIVOBIOT) stock?

    The P/E (price-to-earnings) ratio of Vivo Bio Tech Ltd (VIVOBIOT) is 9.89. The P/B (price-to-book) ratio is 1.32.

  7. Which sector does Vivo Bio Tech Ltd (VIVOBIOT) belong to?

    Vivo Bio Tech Ltd (VIVOBIOT) belongs to the Health Care sector & Biotechnology sub-sector.

  8. How to buy Vivo Bio Tech Ltd (VIVOBIOT) shares?

    You can directly buy Vivo Bio Tech Ltd (VIVOBIOT) shares on Tickertape. Simply sign up, connect your demat account and place your order.